Track topics on Twitter Track topics that are important to you
NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Joe Boorady, president and CEO of TearScience, discusses the new potential for its products that the acquisition by Johnson & Johnson is providing.NEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...